RSV Vaccine May Be Linked to a Slightly Higher Risk of Guillain-Barre Syndrome
NEW YORK — Health officials are investigating whether there’s a link between two new RSV vaccines and cases of a rare nervous system disorder in older U.S. adults. The inquiry is based on fewer than two dozen cases seen among more than 9.5 million vaccine recipients, health officials said Thursday. And the available information is too limited to establish whether the shots caused the illnesses, they added. [time-brightcove not-tgx=”true”] But the numbers are higher than expected and officials are gathering more information to determine if the vaccines are causing the problem. The data was pre...
Source: TIME: Health - March 2, 2024 Category: Consumer Health News Authors: Mike Stobbe/AP Tags: Uncategorized healthscienceclimate wire Source Type: news

Yogurts can now make limited claim that they lower type 2 diabetes risk, FDA says
Sign up for CNN’s Eat, But Better: Mediterranean Style. Our eight-part guide shows you a delicious expert-backed eating lifestyle that will boost your health for life. In a decision nearly five years in the making, the US Food and Drug Administration has decided that yogurts can now make a limited…#mediterraneanstyle #fda #streptococcus #danonenorthamerica #carolinepasserrello #marionnestle #passerrello #nestle #newyorkuniversity #lisadrayer (Source: Reuters: Health)
Source: Reuters: Health - March 2, 2024 Category: Consumer Health News Source Type: news

FDA Roundup: March 1, 2024
SILVER SPRING, Md., March 1, 2024 /PRNewswire/ -- Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA issued a letter of enforcement discretion for certain qualified health claims regarding the consumption of... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - March 1, 2024 Category: Pharmaceuticals Source Type: news

FDA Roundup: March 1, 2024
The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - March 1, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Walgreens, CVS to begin selling mifepristone abortion pill in some stores
CVS and Walgreens said Friday they would begin selling mifepristone abortion pills at their locations in states where it is legal, certified by the Food and Drug Administration. President Joe Biden hailed the decision. (Source: Health News - UPI.com)
Source: Health News - UPI.com - March 1, 2024 Category: Consumer Health News Source Type: news

CVS, Walgreens to Start Selling Abortion Pill, Mifepristone, in Some States
FRIDAY, March 1, 2023 -- CVS and Walgreens announced Friday that they will start dispensing the abortion pill mifepristone this month. The U.S. Food and Drug Administration has certified the nation ' s two largest pharmacy chains to dispense... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 1, 2024 Category: General Medicine Source Type: news

CVS, Walgreens to Start Selling Abortion Pill Mifepristone in Some States
FRIDAY, March 1, 2023 -- CVS and Walgreens announced Friday that they will start dispensing the abortion pill mifepristone this month. The U.S. Food and Drug Administration has certified the nation ' s two largest pharmacy chains to dispense... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 1, 2024 Category: General Medicine Source Type: news

CVS and Walgreens to Begin Offering Abortion Pills in March
CVS and Walgreens will begin dispensing the abortion pill mifepristone this March, the companies confirmed to TIME.  The pharmacies received a certification to offer mifepristone—which is approved by the U.S. Food and Drug Administration to terminate a pregnancy through 10 weeks of gestation, and is often used with misoprostol—to customers with a prescription in compliance with federal and state laws. The news was first reported by the New York Times.  [time-brightcove not-tgx=”true”] Walgreens said that it will start to dispense mifepristone within a week at select locations in New...
Source: TIME: Health - March 1, 2024 Category: Consumer Health News Authors: Solcyré Burga Tags: Uncategorized News News Desk Source Type: news

Rybrevant (amivantamab-vmjw) in Combination With Chemotherapy Is the First FDA Approved Therapy for First-line Treatment of Patients With Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
RARITAN, New Jersey (March 01, 2024)– Johnson& Johnson (NYSE: JNJ) announced today that following a priority review, the U.S. Food and Drug Administration (FDA) has approved Rybrevant® (amivantamab-vmjw) in combination with... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - March 1, 2024 Category: Drugs & Pharmacology Source Type: news

FDA confirms toxic applesauce contaminant was lead chromate
The Food and Drug Administration said Thursday it has confirmed that lead and chromium in applesauce from Ecuador manufacturer Austrofoods are from lead chromate. (Source: Health News - UPI.com)
Source: Health News - UPI.com - February 29, 2024 Category: Consumer Health News Source Type: news

FDA confirms toxic applesauce contaminate was lead chromate
The Food and Drug Administration said Thursday it has confirmed that lead and chromium in applesauce from Ecuador manufacturer Austrofoods are from lead chromate. (Source: Health News - UPI.com)
Source: Health News - UPI.com - February 29, 2024 Category: Consumer Health News Source Type: news

FDA chief sounds alarm over sale of fake weight loss drugs circulating online
GLP-1 agonist drugs are having their moment in the spotlight, but shortages brought on by increased demand are compelling some users to look for quick alternatives that have U.S. Food and Drug Administration (FDA) Commissioner Dr. Robert Califf a bit concerned. Compounded versions of the drugs –…#glp1 #fda #robertcaliff #novonordiskozempic # #wegovy #novonordisk #elililly #mounjaro #gip (Source: Reuters: Health)
Source: Reuters: Health - February 29, 2024 Category: Consumer Health News Source Type: news

QUICK Rheumatism Capsule, Tiger Wang Biaod contains hidden drug ingredient
The Food and Drug Administration is advising consumers not to purchase or use QUICK Rheumatism Capsule, Tiger Wang Biaod, a product promoted and sold for rheumatism on various websites and possibly in some retail stores. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - February 29, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news

SNAKE BONES Anti-Rheumatic Capsules contains hidden drug ingredient
The Food and Drug Administration is advising consumers not to purchase or use SNAKE BONES Anti-Rheumatic Capsules, a product promoted and sold for rheumatism on various websites and possibly in some retail stores. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - February 29, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news

GE HealthCare features new ultrasound, MRI offerings at ECR 2024
VIENNA – GE HealthCare (GEHC) is highlighting a revamped ultrasound product line, the European launch of its Signa Champion 1.5-tesla MRI scanner, and its Care Pathways program in its exhibit area at ECR 2024. In ultrasound, GEHC is debuting Logiq Totus, a midrange, full-body scanner designed for use in a variety of clinical scenarios. Totus includes technology that was previously only available on its higher-end systems, such as its cSound architecture, according to the vendor. Totus features AI-powered voice control as well as decision support via Breast and Thyroid Assistant software from GEHC partner Koios. It’s ...
Source: AuntMinnie.com Headlines - February 29, 2024 Category: Radiology Authors: Erik L. Ridley Tags: Clinical News Ultrasound Source Type: news